PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
0 hedge funds and large institutions have $0 invested in PureTech Health in 2026 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 5 closing their positions.
0.58% less ownership
Funds ownership: 0.58% → 0% (-0.58%)
100% less funds holding
Funds holding: 5 → 0 (-5)
100% less capital invested
Capital invested by funds: $1.96M → $0 (-$1.96M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$1.04M |
| 2 |
Millennium Management
New York
|
-$883K |
| 3 |
PAP
Persistent Asset Partners
Hong Kong
|
-$26.1K |
| 4 |
DP
Diadema Partners
Morristown,
New Jersey
|
-$11.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$297 |
PRTC Hedge Fund Activity: Q2 2026 in Review
0 of the 8,281 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q2 2026, worth a combined $0 — down 100% from $1.96M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PRTC and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Pentwater Capital Management, exiting entirely with an estimated $1.04M sold.
- 0 institutional investors held PureTech Health (PRTC) as of Q2 2026, down from 5 in Q1 2026.
- Funds reported $0 of PureTech Health stock for Q2 2026, down 100% quarter-over-quarter.
- 0 funds opened new PureTech Health positions in Q2 2026 and 5 closed out, a net change of -5 holders.
- The largest PureTech Health seller in Q2 2026 was Pentwater Capital Management, an estimated $1.04M sold.
Based on aggregated 13F filings for Q2 2026.